Roche Holding AG (OTCMKTS:RHHBY) Receives $57.00 Average Price Target from Analysts

Shares of Roche Holding AG (OTCMKTS:RHHBY) have received a consensus rating of “Hold” from the ten analysts that are currently covering the company, MarketBeat.com reports. One equities research analyst has rated the stock with a sell rating, five have assigned a hold rating and four have issued a buy rating on the company. The average 12-month price objective among analysts that have covered the stock in the last year is $57.00.

A number of equities research analysts have weighed in on RHHBY shares. Barclays upgraded shares of Roche from an “equal weight” rating to an “overweight” rating in a research report on Tuesday, January 6th. HSBC reaffirmed a “buy” rating and set a $57.00 price objective on shares of Roche in a research report on Wednesday, December 10th. Zacks Research upgraded shares of Roche from a “strong sell” rating to a “hold” rating in a report on Monday, January 5th. Wolfe Research reissued an “outperform” rating on shares of Roche in a research report on Thursday, February 26th. Finally, JPMorgan Chase & Co. upgraded Roche from an “underweight” rating to a “neutral” rating in a research report on Monday, December 8th.

Hedge Funds Weigh In On Roche

Several institutional investors have recently bought and sold shares of the company. Curio Wealth LLC acquired a new position in shares of Roche in the third quarter valued at approximately $25,000. Oakworth Capital Inc. purchased a new stake in Roche during the 3rd quarter worth approximately $57,000. Salomon & Ludwin LLC lifted its holdings in Roche by 256.6% during the 3rd quarter. Salomon & Ludwin LLC now owns 2,853 shares of the company’s stock worth $129,000 after buying an additional 2,053 shares in the last quarter. Atlas Capital Advisors Inc. purchased a new position in Roche in the 4th quarter valued at approximately $192,000. Finally, Douglass Winthrop Advisors LLC purchased a new position in Roche in the 3rd quarter valued at approximately $201,000.

Roche Price Performance

Shares of RHHBY opened at $48.31 on Friday. The company’s 50-day moving average price is $55.21 and its 200 day moving average price is $49.63. Roche has a 12-month low of $34.75 and a 12-month high of $60.85. The company has a debt-to-equity ratio of 0.72, a quick ratio of 1.12 and a current ratio of 1.38.

About Roche

Roche Holding AG is a Swiss multinational healthcare company headquartered in Basel, founded in 1896 by Fritz Hoffmann‑La Roche. The company operates primarily through two complementary divisions — Pharmaceuticals and Diagnostics — and is known for integrating drug development with diagnostic capabilities to advance personalized healthcare. In the United States and other international markets, shares trade as American Depositary Receipts under the ticker RHHBY (OTCMKTS:RHHBY).

In pharmaceuticals, Roche focuses on developing and commercializing prescription medicines across therapeutic areas including oncology, immunology, infectious diseases and neuroscience, with a notable emphasis on targeted biologics and personalized therapies.